AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 5 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Recs

0
Player Avatar gjenkin1 (< 20) Submitted: 11/30/2011 9:23:43 PM : Outperform Start Price: $43.12 AZN Score: -12.73

its cool

Featured Broker Partners


Advertisement